IP Verse

Compounds For Use In The Treatment Of Erbb2+ Brain Cancer - EP3400943

PATENT ANALYSIS

Patent Details

Grant Date: Dec 2, 2020
Company: ARRAY BIOPHARMA, INC.
Oppositions

More patents of Array Biopharma, Inc.

Want to monitor this patent?

Feel free to send us a message here and we will get back to you